News

Market Alert : Macro And Geopolitical Risks Resurface; Conservative Positioning Advised

Mid-Market: S&P/ASX 200 Trading Higher; All 11 Sectors Are Trading In Green Zone

Source: Kapitales Research

On 27 January 2026, at AEDT 12:45 PM, the benchmark index S&P/ASX 200 is trading higher today, gaining 91.20 points or 1.03%, and is currently trading at 8,951.30 levels. All 11 sectors are trading higher along with the gain in the S&P/ASX 200.

The Telecommunication Services and Energy sectors are the top 2 gaining sectors, gaining 1.59% and 1.43% in their index values.

Capstone Copper Limited (ASX: CSC) and The A2 Milk Corporation Limited (ASX: A2M) are the top-gaining stocks, gaining 7.759% and 4.156% in their stock prices. On the other hand, Alcoa Corporation (ASX: AAI) and Life360 Inc. (ASX: 360) are the top-losing stocks and are declining by 8.692% and 8.228% in their stock prices.

Factors influencing the market-

  • BHP Group Limited’s shares surged 3% to reclaim its title as Australia’s most valuable listed company for the first time in 18 months, overtaking the Commonwealth Bank, which posted a more modest 0.5% rise.
  • The Australian dollar rose to US69.40¢, edging closer to its highest level in nearly three years, as expectations grew that the Reserve Bank would raise the cash rate next month. Anticipation of higher borrowing costs has increased the attractiveness of Australian-dollar assets, including government bonds.
  • Cyclopharm rose sharply today, gaining almost 12%, after its lung imaging technology secured strong backing from prominent US medical specialists. The company said its Technegas system had been adopted as the recommended option for several lung scanning procedures by the leading American nuclear medicine authority, a development expected to support wider uptake across US hospitals.
  • The Dow Jones closed up by 0.64%, S&P 500 gained by 0.50% and Nasdaq was up by 0.43% in the previous session.
  • Hang Seng is up by 0.52%, and FTSE 100 is up by 0.05%.

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au